Endoscopic follow-up period, median (range), month | 20 (6–71) |
Change of lesion size, n (%) | |
Progression | 17 (85) |
Non-Progression | 3 (15) |
Treatment for HNSCC, n (%) | 8 (40) |
Endoscopic resection | 6 (30) |
Surgical resection | 1 (5) |
Chemoradiotherapy | 1 (5) |
Death, n (%) | 5 (29) |
Due to progression of superficial HNSCC | 0 (0) |